Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Bioavailability data recently obtained from Phase 1 study with a stable crystal form of neflamapimod manufactured using a new ...

My name is Leonard and I'm the technical operator for today's call. [Operator Instructions] One last remark, if you would like to follow the presented slides on your ...

The post How to Create Digital Business Cards on Android in 2026 appeared first on Android Headlines.

HUTCHMED divested a 45.0% equity interest in SHPL for $608.5 million in cash in April 2025, retaining a 5.0% equity interest. As a result, HUTCHMED’s share of equity in earnings of SHPL in 2025 ...

A look at how local resource use, material innovation, and autonomous construction are enabling practical habitat development ...

On 3 March 2026, Chancellor Rachel Reeves delivered a speech to the House of Commons, through which the government responded ...

(NASDAQ: ILMN), and Nashville Biosciences, LLC (NashBio), today announced two advancements in scale and depth of the Alliance ...

Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of b ...

Geographic expansion driving ex-China sales growth; indication expansions driving China sales growth - - $457 million net income, driven by profitable core operations and non-core disposal - - Rapidly ...

Collaboration will evaluate INOVIO's INO-5412 (INO-5401 plus INO-9012) in combination with Akeso's cadonilimab as a potential treatment for glioblastoma (GBM), the most common and aggressive ...

The circuit court now expects the Trump administration to file a brief by March 20 explaining why it appealed the district court’s ruling and for Kelly’s legal team to file its reply brief by April 27 ...